Stephan Christgau - Concepedia

Author

Stephan Christgau

Nordic Bioscience (Denmark)

Also Known As

Christgau, S., Christgau, Stephan, S Christgau, S. Christgau, STEPHAN CHRISTGAU, Stephan CHRISTGAU, Stephan Christgau

101

Publications

5.8K

Citations

H-Index

101

Concepts

All Affiliations

Nordic Bioscience (Denmark)Center for Clinical & Basic Research Novo Nordisk (Denmark)Inserm University of California, San Francisco

About

Stephan Christgau is an author at Nordic Bioscience (Denmark) specializing in medicine, orthopaedics, and osteoarthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	28	3.2K
2	Health Sciences	5	5	611
3	Engineering	4	4	462
4	Natural Sciences	4	4	326
5	Public Health	1	1	106

Stephan Christgau

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis Patrick Garnero, X Ayral, Jean‐Charles Rousseau, Arthritis & Rheumatism	2002	397
Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting Per Qvist, Stephan Christgau, B.J. Pedersen, Bone Circadian VariationMedicinePhysiologySerum CtxMenopause	2002	333
Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen Christian Rosenquist, Christian Fledelius, Stephan Christgau, Clinical Chemistry SclerostinBiotin ConjugateImmunologyBone RepairC-terminal Telopeptides	1998	319
Collagen type II C-telopeptide fragments as an index of cartilage degradation Stephan Christgau, Patrick Garnero, Christian Fledelius, Bone Tissue EngineeringMechanobiologyCartilage DegradationEngineeringMusculoskeletal Research	2001	286
Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application Pernille Høegh-Andersen, László B. Tankó, Thomas Levin Andersen, Arthritis Research & Therapy GynecologyFemale Reproductive FunctionCartilage TurnoverOsteoporosisOrthopaedic Surgery	2004	258
A new marker for osteoarthritis: Cross‐sectional and longitudinal approach Max Reijman, Johanna M W Hazes, S.M. Bierma-Zeinstra, Arthritis & Rheumatism	2004	256
Mechanism of circadian variation in bone resorption N. H. Bjarnason, Eva EG Henriksen, Peter Alexandersen, Bone ChronobiologyCircadian VariationMedicinePhysiologyOsteoarthritis	2002	256
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy Stephan Christgau, O Bitsch-Jensen, Nina H. Bjarnason, Bone Therapeutic Drug MonitoringAntiresorptive TherapyTherapeutic EfficacySepsisLaboratory Medicine	2000	197
Association of baseline levels of markers of bone and cartilage degradation with long‐term progression of joint damage in patients with early rheumatoid arthritis Patrick Garnero, Robert Landewé, Maarten Boers, Arthritis & Rheumatism	2002	182
Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. Stephan Christgau, Henk‐Jan Aanstoot, Hanna Schierbeck, The Journal of Cell Biology Protein SecretionMembrane AnchoringGlycobiologyCytoskeletonCellular Physiology	1992	181

Page 1